|
[1]HU XQ, ZHANG JS.Liver biopsy-practice and concepts of pathological diagnosis of hepatic fibrosis[J].J Diagn Concepts Pract, 2005, 4 (1) :71-74, 79. (in Chinese) 胡锡琪, 张锦生.肝穿刺活检-肝纤维化的病理诊断实践与理论[J].诊断学理论与实践, 2005, 4 (1) :71-74, 79.
|
|
[2]ZHANG G, HU Y, LU LG.Opportunity and challenge for diagnosis and treatment of hepatic fi brosis[J].World Chin J Dig, 2015, 23 (36) :5743-5749. (in Chinese) 张国, 胡烨, 陆伦根.肝纤维化诊治机遇与挑战[J].世界华人消化杂志, 2015, 23 (36) :5743-5749.
|
|
[3]ZHENG M, CAI WM, WENG HL, et al.ROC curve in evaluation of serum fibrosis index for diagnosing hepatic fibrosis[J].Chin J Infect Dis, 2002, 20 (4) :225-228. (in Chinese) 郑敏, 蔡卫民, 翁红雷, 等.ROC曲线评价血清纤维化指标对诊断肝纤维化的价值[J].中华传染病杂志, 2002, 20 (4) :225-228.
|
|
[4]TAO J, PENG HQ, CAI WM, et al.Influence factors of serum fibrosis markers in liver fibrosis[J].World J Gastroenterol, 2003, 9 (11) :2497-2500.
|
|
[5]SHI YL, HE HL, WU XH, et al.The relationship between the levels of serum HA、LN、ⅣC and PⅢNP of chronic hepatitis and indexes of live fibrosis[J].Inter Med Health Guid News, 2006, 12 (8) :81-83. (in Chinese) 石亚玲, 何浩岚, 吴雪辉, 等.慢性乙型肝炎患者血清HA、LN、ⅣC及PⅢNP含量与肝纤维化程度的关系探讨[J].国际医药卫生导报, 2006, 12 (8) :81-83.
|
|
[6]LI X, ZHANG LX, CHEN YB, et al.Study on the correlation between serological indicators of hepatic fibrosis and PAPP and hepatic fibrosis[J].Chin Med Biotechnol, 2009, 4 (5) :350-354. (in Chinese) 李忻, 张立新, 陈亚宝, 等.血清肝纤维化指标及PAPP指数与肝纤维化的相关性研究[J].中国医药生物技术, 2009, 4 (5) :350-354.
|
|
[7]XUE YJ, YANG GR, ZHANG WJ, et al.Diagnostic value of detection of serum HA、LN、PCⅢ、CⅣfor liver fibrosis[J].Chin J Integr Tradit West Med Liver Dis, 2010, 20 (3) :178-179. (in Chinese) 薛永杰, 杨国嵘, 张文杰, 等.透明质酸、层粘连蛋白、Ⅲ型前胶原和Ⅳ型胶原血清学指标对肝硬化诊断的价值[J].中西医结合肝病杂志, 2010, 20 (3) :178-179.
|
|
[8]LIN LJ, XU LM.Whether the four serum markers of liver fibrosis have a reliable diagnostic value[J].Chin Hepatol, 2012, 17 (6) :433-435. (in Chinese) 林利静, 徐列明.肝纤维化四项血清标志物是否存在可信诊断价值[J].肝脏, 2012, 17 (6) :433-435.
|
|
[9]ZHANG YG, ZHAO SX, ZHOU GD, et al.Correlation of Fibro Touch and Fibro Scan with the stage of primary biliary cirrhosis[J].Chin JHepatol, 2016, 24 (12) :902-906. (in Chinese) 张玉果, 赵素贤, 周光德, 等.Fibro Touch、Fibro Scan与原发性胆汁性肝硬化分期的相关性分析[J].中华肝脏病杂志, 2016, 24 (12) :902-906.
|
|
[10]GE N, HE Q.Ultrasound elastography for evaluation of classification of liver fibrosis[J].J Clin Hepatol, 2016, 32 (12) :2379-2382. (in Chinese) 葛娜, 何茜.超声弹性成像对肝纤维化分级的评估[J].临床肝胆病杂志, 2016, 32 (12) :2379-2382.
|
|
[11]WELLS RG.The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis[J].J Clin Gastroenterol, 2005, 39 (4) :s158-s161.
|
|
[12]SANADA M, EBARA M, FUKUDA H, et al.Clinical evaluation of sonoelasticity measurement in liver using ultrasonic imaging of internal forced low frequency vibration[J].Ultrasound Med Biol, 2000, 26 (9) :1455-1460.
|
|
[13]VIZZUTTI F, ARENAL U, MARRA F, et al.Elastography for the non-invasive assessment of liver disease:limitation and future developments[J].Gut, 2009, 58 (2) :157-160.
|
|
[14]XU LM.Traditional Chinese medicine therapy and assessment of liver fibrosis[J].Drug Eval, 2007, 4 (4) :285-288. (in Chinese) 徐列明.肝纤维化中医药治疗和评价[J].药品评价, 2007, 4 (4) :285-288.
|
|
[15]LI ZJ, ZHANG XE, SU GQ, et al.Special project of basic research on traditional Chinese medicine theories in 973 Program Compilation of project achievements from 2005 to 2006[M].Beijing:China Press of Traditional Chinese Medicine, 2011:179. (in Chinese) 李振吉, 张先恩, 苏刚强, 等.973计划中医理论基础研究专项2005-2006年项目成果集[M].北京:中国中医药出版社, 2011:179.
|
|
[16]FRIEDMAN SL, BANSAL MB.Reversal of hepatic fibrosis-fact or fantasy?[J].Hepatolology, 2006, 43 (2) :s82-s88.
|
|
[17]LIN LJ, CHEN GF, GU HT, et al.Performance of Fibro Scan in evaluating the curative effects of traditional Chinese medicine on liver fibrosis[J].Chin J Hepatol, 2014, 22 (2) :113-117. (in Chinese) 林利静, 陈高峰, 顾宏图, 等.Fibro Scan评判中医药抗肝纤维化疗效的价值[J].中华肝脏病杂志, 2014, 22 (2) :113-117.
|
|
[18]SUN LD, ZHANG M, TANG Z.An analysis on prognosis in 289patients with decompensatory cirrhosis[J].Shandong Med J, 2009, 49 (32) :10-12. (in Chinese) 孙立东, 张玫, 汤哲.289例失代偿期肝硬化患者预后分析[J].山东医药, 2009, 49 (32) :10-12.
|
|
[19]SHI Y, SONG T, SHAN MJ.Clinical effect of Fuzheng Huayu capsules combined with tranexamic acid in treatment of chloasma[J].Chin J Dermato Venerol Integ Trad W Med, 2016, 15 (4) :239-240. (in Chinese) 时悦, 宋婷, 单敏洁.扶正化瘀胶囊联合氨甲环酸治疗黄褐斑的临床观察[J].中国中西医结合皮肤性病学杂志, 2016, 15 (4) :239-240.
|
|
[20]GUO XF, ZHU Q, LYU WH, et al.Primary application of chronic liver disease questionnaire in HBs Ag carriers[J].Jilin Med J, 2010, 31 (11) :1472-1474. (in Chinese) 郭新峰, 朱泉, 吕渭辉, 等.慢性肝病问卷在乙型肝炎病毒携带者中的初步试用[J].吉林医学, 2010, 31 (11) :1472-1474.
|
|
[21]ZHANG H, LIU P.A study on the thoughts and methods for quantitative research on TCM syndrome[J].Chin J Basic Med Tradit Chin Med, 2009, 15 (8) :574-576. (in Chinese) 张华, 刘平.中医证候量化研究的思路与方法探析[J].中国中医基础医学杂志, 2009, 15 (8) :574-576.
|
|
[22]WU CH, DENG QW, JI XS, et al.Preliminary use of the CLDQ in chronic hepatitis B patients[J].Chin J Clin Psychol, 2003, 11 (1) :60-62. (in Chinese) 吴创鸿, 邓启文, 纪晓抒, 等.慢性肝病问卷在慢性乙型肝炎患者中的试用[J].中国临床心理学杂志, 2003, 11 (1) :60-62.
|
|
[23]ZHANG H, LV H, HUANG PX, et al.Comparative study of TCMsyndrome scale for liver disease and chronic liver disease questionnaire based on assessment of posthepatitic cirrhosis[J].Evid Based Complement Alternat Med, 2012, 2012:496575.
|
|
[24]CHENG XJ, LU W, HOU W, et al.Diagnostic value of Fibro Test combined with Fibro Scan for liver fibrosis in patients with chronic hepatitis B[J].J Clin Hepatol, 2014, 30 (5) :424-427. (in Chinese) 程晓静, 陆伟, 侯伟, 等.Fibro Test联合Fibro Scan对慢性乙型肝炎肝纤维化的诊断价值[J].临床肝胆病杂志, 2014, 30 (5) :424-427.
|
|
[25]LEI CD, REN Y, ZHENG SJ, et al.Diagnostic value of the APRIindex for liver fibrosis in a Chinese patients population with chronic hepatitis C acquired from blood transfusion[J].J Clin Hepatol, 2013, 29 (5) :343-347. (in Chinese) 雷成多, 任艳, 郑素军, 等.APRI指数对定西地区感染HCV的供血员肝纤维化的诊断价值[J].临床肝胆病杂志, 2013, 29 (5) :343-347.
|
DownLoad: